The eMap-Coronavirus2019

EU RESEARCH AND INNOVATION

Treatments

Last update Date/Time:

​This Interactive Neural eMap offers an updated mapping of new and ongoing EU Projects on Treatments of new Coronavirus.

 

Outline show/hide

EU RESPONSE TO COVID-19

Research & Innovation
TREATMENTS

COMBACTE-NET - Combatting bacterial resistance in Europe (NL)

This Innovative Medicines Initiative (IMI) project is dedicated to building strong clinical, laboratory and research networks across Europe.

• Project details

• Story: Boosting the fight against drug-resistant bacteria in hospitals

EXCALATE (IT)

Stemming from the Antarex project, EXCALATE operates the Italian Supercomputer in CINECA.

The platform is analysing COVID-19 proteins based on data available from the scientific community in order to accelerate the search of an effective therapy. A new project – Exscalate4CoV. (E4C) invites collaboration to screen potential drugs.

• More information

INFO

INNOVATIVE MEDICINES INITIATIVE

DIAGNOSTIC PROJECTS

• DECISION (D)

  A minituarized disposable molecular diagnostics platform for combatting coronavirus infections

  Partners from Germany, Italy, Spain

  The DECISION project want to give test’s result in 15 minutes. They’re working on a low-cost, miniaturised, disposable molecular diagnostic system that will make it possible to test patients with laboratory quality performance pretty much anywhere and give them their results in a matter of minutes.

• COVID-RED (NL)

  COVID-19 infections - remote early detection

  Partners from Denmark, Lithuania, the Netherlands, Switzerland, UK

  The project will combine expertise in clinical epidemiology with digital devices (such as wearables and mobile apps) to rapidly and reliably detect cases so that they can be prioritised for testing.

• DRAGON (B)

  Rapid and secure AI imaging based diagnosis, stratification, follow-up, and preparedness for coronavirus pandemics

  21 partners from Belgium, China, Italy, the Netherlands, Switzerland, UK

  The DRAGON project will apply artificial intelligence and machine learning to deliver a decision support system for improved and more rapid diagnosis and prognosis. Citizens and patients will be involved in the development of the system.

• RAPID-COVID (UK)

  Robust automation and point of care identification of COVID

  5 partners from France, Slovenia, Spain, UK

  While the world focuses on COVID-19, other infectious diseases with similar symptoms continue to circulate. The RAPID-COVID project aims to develop a diagnostic test that can simultaneously detect SARS-CoV-2 as well as 30 other common respiratory bacteria and viruses. This will ensure COVID-19 patients are quickly isolated and all patients receive the right treatment. It will also avoid the unnecessary use of antibiotics.

• KRONO (UK)

  Evaluation of a production ready portable, point-of-need platform (instrument and reagents), direct from nasal swab test for the molecular diagnostic detection of COVID-19 infection.

  5 partners from France, Italy, UK

  Currently, COVID-19 diagnostic tests need to be processed by an expert in a laboratory. The KRONO project aims to change that by delivering a simple test that can be used at a doctor’s office or a patient’s home (for example) and would deliver results in just 40 minutes. While the focus of the project is on the SARS-CoV-2 virus, the team also plans to demonstrate a pipeline for rapidly deploying new tests in response to future outbreaks.

TREATMENT PROJECTS

• CARE - Corona accelerated R&D in Europe. (FR)

  The project aims to identify candidates among existing drugs that could be effective as treatments (drug repurposing), and develop new drugs specially designed to tackle the virus, in order to deliver treatments for the current outbreak, as well as future coronavirus outbreaks.

• MAD-CoV 2 (SE)

  Modern approaches for developing antivirals against SARS-CoV 2. The project aims to develop new COVID-19 treatments by engineering human tissue to test new antiviral treatments. Led by Statens Veterinaermedicinska Anstalt (SE)

• IMPENTRI (IRL)

  Development of Impentri, an intravenous imatinib formulation for COVID-19 acute respiratory distress syndrome (ARDS).

FIGHT-NCOV (SE)

Fighting-off Coronavirus (SARS-CoV-2) with broad-spectrum antivirals: establishing animal challenge model, that will prepare the way towards broad-spectrum antiviral treatments that can be taken intranasally.

• Project details

• Story: EU grant to Stockholm University for Coronavirus Research

MANCO (NL)

Monoclonal Antibodies against 2019 New Coronavirus.

• Project details

• Testimonial from Franck Grosveld (Cell biologist at Harbour Antibodies, Rotterdam)

• Futuris video: Europe supercharges research in the battle against COVID-19

RiPCoN (DE)

Rapid interaction profiling of 2019-nCoV for network-based deep drug repurpose learning (DDRL).

• Project details

• Story: INET coordinates new EU research project on COVID-19

SCORE (NL)

Swift COronavirus therapeutics Response. The project aims to develop of combination anti-viral treatments for patients infected with the coronavirus.

• Project details

• Story: LUMC does research on new coronavirus inhibitors

SOLNATIDE (AU)

Exploration of safety, tolerability and clinical efficacy of Solnatide IMP in patients infected with the 2019 new coronavirus.

• Project details

SYNBIO4FLAV (ES)

The SynBio4Flav platform is using synthetic biology to provide a cost-effective alternative to current flavonoid production.

• SynBio4Flav website

• Project details

ATAC (SE)

Antibody therapy against coronavirus (COVID-2019).

• Project details

• Story: Three KI-led coronavirus projects selected in EU funding round

• Story: ‘The aim is to find the monoclonal’: the hunt for the antibody to treat Covid-19

BIOEXCEL (SE)

Another example of using the power of supercomputers is the BioExcel project.

• More information

CORONAB (SE)

Nanobodies and antibodies against 2019-nCoV. The project aims to rapidly identify, validate and produce antibodies that block the ability of the virus to infect cells, for treatment and prevention in humans.

• Project details

• Story: Three KI-led coronavirus projects selected in EU funding round

Go to the online App